048410 - Hyundai Bioscience Co., Ltd.

048410 Summary
Chemicals
Stock Price & Overview
₩6,210 +160 (+2.64%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩6,210  ≈ US$4  ·  Market cap ₩0.6tn (≈ $428m)

Material matter affecting investment judgment (clinical trial plan amendment applied for)

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항(임상시험계획변경승인신청) (전립선암 치료제 CPPCA07의 1상 임상시험계획 변경승인 신청)